Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.
2.

Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain.

Morissette M, Le Saux M, D'Astous M, Jourdain S, Al Sweidi S, Morin N, Estrada-Camarena E, Mendez P, Garcia-Segura LM, Di Paolo T.

J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):327-38. Epub 2007 Sep 7. Review.

PMID:
17936613
3.

Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease.

Al Sweidi S, Sánchez MG, Bourque M, Morissette M, Dluzen D, Di Paolo T.

J Neuroendocrinol. 2012 Jan;24(1):48-61. doi: 10.1111/j.1365-2826.2011.02193.x. Review.

PMID:
21790809
4.

Estrogen and SERM neuroprotection in animal models of Parkinson's disease.

Morissette M, Al Sweidi S, Callier S, Di Paolo T.

Mol Cell Endocrinol. 2008 Aug 13;290(1-2):60-9. doi: 10.1016/j.mce.2008.04.008. Epub 2008 Apr 22. Review.

PMID:
18515001
5.

Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease.

Bourque M, Dluzen DE, Di Paolo T.

Front Neuroendocrinol. 2012 Apr;33(2):169-78. doi: 10.1016/j.yfrne.2012.02.003. Epub 2012 Mar 1. Review.

PMID:
22387674
6.

Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection.

Garcia-Segura LM, Sanz A, Mendez P.

Neuroendocrinology. 2006;84(4):275-9. Epub 2006 Nov 23. Review.

PMID:
17124377
7.

17beta-estradiol signaling in skeletal muscle cells and its relationship to apoptosis.

Boland R, Vasconsuelo A, Milanesi L, Ronda AC, de Boland AR.

Steroids. 2008 Oct;73(9-10):859-63. doi: 10.1016/j.steroids.2007.12.027. Epub 2008 Jan 4. Review.

PMID:
18272190
8.

Neuroprotective actions of sex steroids in Parkinson's disease.

Bourque M, Dluzen DE, Di Paolo T.

Front Neuroendocrinol. 2009 Jul;30(2):142-57. doi: 10.1016/j.yfrne.2009.04.014. Epub 2009 May 3. Review.

PMID:
19410597
9.

Signaling by insulin-like growth factor 1 in brain.

Bondy CA, Cheng CM.

Eur J Pharmacol. 2004 Apr 19;490(1-3):25-31. Review.

PMID:
15094071
10.

Apomorphine as a neuroprotective drug: a study in MPTP-treated mice and potential relevance to ischemia.

Orzi F, Castri P, Fornai F.

Funct Neurol. 2001;16(4 Suppl):153-8. Review. No abstract available.

PMID:
11996511
11.

Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease.

Litim N, Morissette M, Di Paolo T.

Neurosci Biobehav Rev. 2015 Dec 17. pii: S0149-7634(15)30067-1. doi: 10.1016/j.neubiorev.2015.09.024. [Epub ahead of print] Review.

PMID:
26708712
12.

Neuroprotective role of testosterone in the nervous system.

Białek M, Zaremba P, Borowicz KK, Czuczwar SJ.

Pol J Pharmacol. 2004 Sep-Oct;56(5):509-18. Review.

13.

Impact of clinically relevant progestins on the neural effects of estradiol and the signaling pathways involved.

Nilsen J, Deng J, Brinton RD.

Drug News Perspect. 2005 Nov;18(9):545-53. Review.

PMID:
16421627
Items per page

Supplemental Content

Write to the Help Desk